Overview

Demonstrate Efficacy and Safety of Metastatic Breast Cancer

Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to to demonstrate equivalence
Phase:
Phase 3
Details
Lead Sponsor:
Celltrion
Treatments:
Albumin-Bound Paclitaxel
Paclitaxel
Trastuzumab